Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	25.51	40.24	53.5	102.53	160.92	25.44
Short-Term Investments	97.46	145.19	23.47	-	-	-
Cash & Short-Term Investments	122.97	185.43	76.97	102.53	160.92	25.44
Cash Growth	-16.14%	140.91%	-24.93%	-36.29%	532.51%	1259.08%
Accounts Receivable	-	-	1.03	0.53	0.47	-
Other Receivables	0.88	1.05	0.82	-	-	-
Receivables	0.88	1.05	1.86	0.53	0.47	-
Prepaid Expenses	5.68	2.16	0.99	1.62	0.9	0.67
Total Current Assets	129.52	188.63	79.82	104.68	162.29	26.11
Property, Plant & Equipment	18.46	20.43	24.64	27.62	4.08	2.39
Long-Term Deferred Charges	-	-	-	-	3.17	0.59
Other Long-Term Assets	0.88	0.53	0.65	0.76	0.39	0.14
Total Assets	148.86	209.58	105.11	133.05	169.93	29.23
Accounts Payable	0.85	1.12	0.61	1.1	1.44	2.15
Accrued Expenses	7.03	7.39	8.02	10.15	10.13	3.16
Current Portion of Leases	3.17	3.74	3.6	3.49	0.43	0.46
Current Unearned Revenue	-	-	-	10.89	7.3	-
Total Current Liabilities	11.12	12.25	12.23	25.63	19.31	5.76
Long-Term Leases	8.52	10.61	13.32	15.96	1.31	1.66
Long-Term Unearned Revenue	-	-	-	15.64	21.68	-
Other Long-Term Liabilities	-	0.07	25.17	0.12	0.08	5.31
Total Liabilities	19.64	22.94	50.72	57.34	42.37	12.73
Common Stock	0	0	-	-	-	-
Additional Paid-In Capital	438.91	433.45	18.99	11.9	4.95	0.41
Retained Earnings	-309.78	-246.68	-181.31	-152.59	-93.8	-21.98
Comprehensive Income & Other	0.09	-0.13	0.31	-	-	-
Total Common Equity	129.22	186.64	-162.02	-140.7	-88.86	-21.57
Shareholders' Equity	129.22	186.64	54.4	75.72	127.56	16.5
Total Liabilities & Equity	148.86	209.58	105.11	133.05	169.93	29.23
Total Debt	11.69	14.35	16.91	19.45	1.74	2.12
Net Cash (Debt)	111.28	171.07	60.06	83.08	159.18	23.33
Net Cash Growth	-15.48%	184.84%	-27.71%	-47.81%	582.42%	-
Net Cash Per Share	4.56	15.19	74.82	108.36	232.10	36.94
Filing Date Shares Outstanding	24.54	24.36	0.81	0.77	0.71	0.73
Total Common Shares Outstanding	24.54	24.29	0.81	0.77	0.71	0.73
Working Capital	118.41	176.38	67.59	79.05	142.98	20.34
Book Value Per Share	5.26	7.68	-200.07	-183.50	-124.96	-29.71
Tangible Book Value	129.22	186.64	-162.02	-140.7	-88.86	-21.57
Tangible Book Value Per Share	5.26	7.68	-200.07	-183.50	-124.96	-29.71
Machinery	13.92	11.88	11.24	-	2.78	0.53
Leasehold Improvements	0.87	0.41	0.39	-	0.04	0.04

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q